Phase 2 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with lupus nephritis (lupus affecting the kidneys), confirmed by a kidney biopsy, specifically classified as Class III, IV, or V
- You have chronic kidney disease with a kidney function level (eGFR) between 15 and 60 mL/min
- Your lupus is currently in a quiet/stable phase, meaning your overall lupus activity score is low and your kidneys are not currently showing signs of active lupus flare
- You have been on a steady, unchanged dose of prednisolone (a steroid, 5–7.5 mg per day) for at least the past 3 months, either on its own or combined with a stable dose of either MMF (mycophenolate mofetil, up to 1.5 g/day) or AZA (azathioprine, up to 150 mg/day)
Who may not be able to join:
- You have a kidney disease confirmed by biopsy that is caused by something other than lupus, or you have an inherited kidney condition
- You have Type 1 diabetes
- Your kidney disease is at the most advanced stage (Stage 5), or you are already on dialysis or another form of kidney replacement therapy
- You get urinary tract infections (UTIs) often
- You have a history of a serious condition called ketoacidosis (a dangerous build-up of acids in the blood)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Desmond Yap, MD (HK), The University of Hong Kong
Phone: 85222554385
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
eGFR reduction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.